Future studies can investigate how TNFRSF13B works for the canonical NF-κB and MAPK/p38 stimulation and whether a TNFRSF13B-related gene signature can be used for prognosis prediction for MM patients. Here, NFKB1 is linked to Miyoshi myopathy.